Dynavax Technologies Corporation - Common Stock (DVAX)

A fundamental and technical analysis of (NASDAQ:DVAX): Why DYNAVAX TECHNOLOGIES CORP (NASDAQ:DVAX) is Poised for High Growth.

DVAX earnings call for the period ending December 31, 2024.

What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 10-14, 2025.

Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.

DVAX earnings call for the period ending September 30, 2024.

DVAX earnings call for the period ending June 30, 2024.

DVAX stock results show that Dynavax Technologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Response Letter.

DVAX earnings call for the period ending March 31, 2024.

DVAX stock results show that Dynavax Technologies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

DVAX earnings call for the period ending December 31, 2023.

Executive changes and a bullish analyst take combined to boost sentiment on the company.

Analyst stock picks for outsized growth potential mean these companies should handily outperform the market averages.

DVAX earnings call for the period ending September 30, 2023.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Restaurant Brands International Inc. (NYSE: QSR) is a buy.

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.

Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.

DVAX earnings call for the period ending June 30, 2023.